MESO FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action – MESOGlobeNewsWire • 12/03/20
MONDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 12/03/20
MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 12/02/20
FDA Grants Fast Track Designation for Remestemcel-L in the Treatment of Acute Respiratory Distress Syndrome Due to COVID-19GlobeNewsWire • 12/02/20
Rosen, Top Ranked Investor Counsel, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESONewsfile Corp • 12/01/20
MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 12/01/20
ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESOPRNewsWire • 11/28/20
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mesoblast Limited of Class Action Law Suit and Upcoming Deadline – MESOGlobeNewsWire • 11/26/20
ROSEN, A TOP RANKED FIRM, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESONewsfile Corp • 11/21/20
Mesoblast Enters Global Collaboration for Development, Manufacture and Commercialization of Remestemcel-LGlobeNewsWire • 11/19/20
Rosen, A Trusted and Leading Law Firm, Reminds Mesoblast Limited Investors of Important Deadline in Securities Class Action; Encourages Investors with Large Losses to Contact Firm - MESONewsfile Corp • 11/17/20
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Mesoblast Limited Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESOPRNewsWire • 11/14/20
Rosen, National Trial Counsel, Reminds Mesoblast Limited Investors of Important Deadline in Securities Class Action - MESONewsfile Corp • 11/11/20
Second Interim Analysis of Clinical Outcomes After 135 Patients Results in Recommendation to Continue Remestemcel-L Phase 3 Trial in COVID-19 ARDSGlobeNewsWire • 11/11/20
Rosen, Top Ranked Investor Counsel, Reminds Mesoblast Limited Investors of Important Deadline in Securities Class Action - MESONewsfile Corp • 11/07/20
Rosen, National Trial Lawyers, Reminds Mesoblast Limited Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESONewsfile Corp • 10/31/20
Pomerantz Law Firm Announces the Filing of a Class Action against and Mesoblast Limited Certain Officers - MESOPRNewsWire • 10/31/20
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mesoblast Limited (MESO)PRNewsWire • 10/30/20
Update on Remestemcel-L For the Treatment of COVID-19 ARDS and Steroid-Refractory Acute GVHDGlobeNewsWire • 10/29/20
ROSEN, A LEADING LAW FIRM, Reminds Mesoblast Limited Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESOPRNewsWire • 10/28/20
MESO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Mesoblast Limited Investors of Class Action and Lead Plaintiff Deadline: December 7, 2020Newsfile Corp • 10/23/20
